Search results
Showing 2311 to 2325 of 9039 results
Awaiting development Reference number: GID-TA11840 Expected publication date: TBC
Electrocautery cutting balloon treatment for pelviureteric junction obstruction
Topic prioritisation
Awaiting development Reference number: GID-TA12031 Expected publication date: TBC
Larotrectinib for treating NTRK fusion-positive advanced solid tumours (MA review of TA630) [ID6292]
In development Reference number: GID-TA11565 Expected publication date: 18 November 2026
In development Reference number: GID-TA11330 Expected publication date: 14 October 2026
Awaiting development Reference number: GID-TA11623 Expected publication date: TBC
Daratumumab for treating high-risk smouldering multiple myeloma [ID6214]
Awaiting development Reference number: GID-TA11198 Expected publication date: TBC
Pelabresib with ruxolitinib for treating myelofibrosis [TSID12391]
Awaiting development Reference number: GID-TA12017 Expected publication date: TBC
Depemokimab for treating eosinophilic granulomatosis with polyangiitis [TSID12383]
Awaiting development Reference number: GID-TA12007 Expected publication date: TBC
In development Reference number: GID-TA11625 Expected publication date: 16 December 2026
Treprostinil diethanolamine for treating pulmonary arterial hypertension [ID6366]
Awaiting development Reference number: GID-TA11123 Expected publication date: TBC
Awaiting development Reference number: GID-TA10967 Expected publication date: TBC
Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [ID6720]
Awaiting development Reference number: GID-TA11874 Expected publication date: TBC
Nipocalimab for treating generalised myasthenia gravis [ID6562]
Awaiting development Reference number: GID-TA11492 Expected publication date: TBC